A critical appraisal of "Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus

被引：46

作者：

Bharucha, Tehmina ^{[1
]}

Ming, Damien ^{[2
]}

Breuer, Judith ^{[1
,3
]}

机构：

[1] UCL, Div Infect & Immun, Cruciform Bldg, London WC1E 6BT, England

[2] Imperial Coll London, Dept Infect Dis & Immun, London, England

[3] Great Ormond St Hosp Sick Children, Microbiol Virol & Infect Control, London, England

来源：

HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2017年 / 13卷 / 08期

关键词：

immunisation; vaccination; public health; shingles; varicella; herpes zoster virus; CANDIDATE VACCINE; IMMUNE-RESPONSES; TERM PERSISTENCE; LONG-TERM; IMMUNOGENICITY; SAFETY; ADULTS; EFFICACY; GLYCOPROTEINS; INFECTION;

D O I：

10.1080/21645515.2017.1317410

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

HZ/Su, branded as Shingrix', is one of the newest vaccines to be submitted for multi-national regulatory approval. It is targeted to prevent shingles, a global concern with aging populations. A live attenuated vaccine for shingles has been available for over a decade, however it is contraindicated in specific subgroups of people, and there are added concerns regarding long-term immunogenicity. HZ/Su is the first subunit vaccine developed to protect against shingles. This paper provides a critical appraisal of current evidence regarding HZ/Su.

引用

页码：1789 / 1797

页数：9

共 44 条

[31] Epidemiology of primary varicella and herpes zoster hospitalizations: The pre-varicella vaccine era [J].

Lin, F ;

Hadler, JL .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06) :1897-1905

[32] The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells [J].

Mo, CJ ;

Lee, J ;

Sommer, M ;

Grose, C ;

Arvin, AM .

VIROLOGY, 2002, 304 (02) :176-186

[33] Decreasing Incidence of Herpes Zoster in the Highly Active Antiretroviral Therapy Era [J].

Moanna, Abeer ;

Rimland, David .

CLINICAL INFECTIOUS DISEASES, 2013, 57 (01) :122-125

[34] Long-term Persistence of Zoster Vaccine Efficacy [J].

Morrison, Vicki A. ;

Johnson, Gary R. ;

Schmader, Kenneth E. ;

Levin, Myron J. ;

Zhang, Jane H. ;

Looney, David J. ;

Betts, Robert ;

Gelb, Larry ;

Guatelli, John C. ;

Harbecke, Ruth ;

Pachucki, Connie ;

Keay, Susan ;

Menzies, Barbara ;

Griffin, Marie R. ;

Kauffman, Carol A. ;

Marques, Adriana ;

Toney, John ;

Boardman, Kathy ;

Su, Shu-Chih ;

Li, Xiaoming ;

Chan, Ivan S. F. ;

Parrino, Janie ;

Annunziato, Paula ;

Oxman, Michael N. .

CLINICAL INFECTIOUS DISEASES, 2015, 60 (06) :900-909

[35] Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations [J].

Newman, MJ ;

Wu, JY ;

Gardner, BH ;

Anderson, CA ;

Kensil, CR ;

Recchia, J ;

Coughlin, RT ;

Powell, MF .

VACCINE, 1997, 15 (09) :1001-1007

[36] Immunization to reduce the frequency and severity of herpes zoster and its complications [J].

Oxman, MN .

NEUROLOGY, 1995, 45 (12) :S41-S46

[37]

Oxman MN, 2012, NEW ENGL J MED, V367, P1287

[38] Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy [J].

Schmader, K. E. ;

Oxman, M. N. ;

Levin, M. J. ;

Johnson, G. ;

Zhang, J. H. ;

Betts, R. ;

Morrison, V. A. ;

Gelb, L. ;

Guatelli, J. C. ;

Harbecke, R. ;

Pachucki, C. ;

Keay, S. ;

Menzies, B. ;

Griffin, M. R. ;

Kauffman, C. ;

Marques, A. ;

Toney, J. ;

Keller, P. M. ;

Li, X. ;

Chan, I. S. F. ;

Annunziato, P. .

CLINICAL INFECTIOUS DISEASES, 2012, 55 (10) :1320-1328

[39] A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients [J].

Stadtmauer, Edward A. ;

Sullivan, Keith M. ;

Marty, Francisco M. ;

Dadwal, Sanjeet S. ;

Papanicolaou, Genovefa A. ;

Shea, Thomas C. ;

Mossad, Sherif B. ;

Andreadis, Charalambos ;

Young, Jo-Anne H. ;

Buadi, Francis K. ;

El Idrissi, Mohamed ;

Heineman, Thomas C. ;

Berkowitz, Elchonon M. .

BLOOD, 2014, 124 (19) :2921-2929

[40] A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children [J].

Stassijns, Jorgen ;

Bollaerts, Kaatje ;

Baay, Marc ;

Verstraeten, Thomas .

VACCINE, 2016, 34 (06) :714-722

← 1 2 3 4 5 →